Skip to main content

Table 2 Distribution of the administered CT and response rates among patients

From: Association between gene expression profile of the primary tumor and chemotherapy response of metastatic breast cancer

  Response N %
First line chemotherapy A-CT no 25 48,1%
yes 27 51,9%
NA/NT-CT no 14 66,7%
yes 7 33,3%
T-CT no 11 78,6%
yes 3 21,4%
Second line chemotherapy A-CT no 10 71,4%
yes 4 28,6%
NA/NT-CT no 20 87,0%
yes 2 8,7%
T-CT no 17 68,0%
yes 8 32,0%
  1. Abbreviations: A-CT anthracycline containing chemotherapy, NA/NT-CT non-anthracyline/non-taxane containing chemotherapy, T-CT taxane containing chemotherapy